知临医药业务

知临集团医药业务:正寻求开发多个药物分子(包括运用天然物质的提炼物或衍生物用于疾病治疗)和
相关技术以治疗及诊断人类疾病,适应症范围包括神经内科、传染病、胃肠病、癌症及其他疾病。

Acticule

Acticule专注於传染病治疗的临床研发工作,主要研究类别包括可成为口服及注射形式的抗病毒和细菌抗生素的候选药物。目前,Acticule设立了一所药物发现中心,配备了全自动化的机械平台进行高通量筛选程序,创建可进行早期及临床研究的严选及通过测试的候选药物的永续生产管道。

Videns

Videns专注於神经退行性疾病和影像诊断发明的大型战略临床研发工作。目前的主要项目包括:(i) 应用於早期诊断认知障碍症的磁共振成像原理的医学成像技术;(ii) 应用於神经退行性疾病治疗的自噬增强的mTOR非依赖性TFEB激活剂;(iii) 应用於诊断认知障碍症的无创视网膜图像技术。

Claves

Claves专注於肠胃科治疗候选药物的临床研发工作。正处於研发阶段及将会进行研发的潜力候选药物集中於的肠道菌群衍生代谢物调节,以预防及治疗疾病。Claves亦正在探索建设肠道菌群的调节平台,用以孕育各种能微调肠道菌群程度丶有广泛医疗用途的崭新处方候选药物。

Scipio

Scipio专注於癌症治疗药物和诊断方法的研发工作。目前主要的项目包括基於喹啉类和食管癌分子肿瘤学的崭新抗癌药剂。

Nativus

Nativus专注於天然健康或利用天然成分(例如绿茶丶大蒜和山药)提取物开发的医药和补健产品的研发工作。目前,Nativus集中研究女性健康和视力保养,其正在研发的先导候选药物应用於子宫内膜异位症和由痛经而引起的女性疼痛症状之治疗。

Aptorum Pharmaceutical Development

Aptorum Pharmaceutical Development ("APD") 主责自设药品研发中心的营运,并正进行进一步扩展。APD的主要任务是推进公司旗下项目的临床前研究,并委任外部获cGLP, cGMP 及cGCP认证的委托研究机构进行监管机构要求的临床发展计划。

×
使用条款

This Website contains information concerning Aptorum Group Limited (“Aptorum Group”) and its affiliates that may be useful to Aptorum Group’s customers, suppliers, employees, directors and shareholders, as well as members of the general public. However, by using this Website you are accepting all of the terms of this disclaimer notice, including exclusions and limitations of liability. If you do not agree with anything in this notice, you should not use this Website.

Aptorum Group does not claim ownership of the materials and product images on the Website that are provided to us by our third party suppliers.

Where our Website contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them. These links are provided solely as a convenience to you and not as an endorsement by us of the contents on such third party websites.

While reasonable efforts are made to ensure that the contents of this Website are accurate, this Website and its contents are provided on an “as is,” “as available” basis, without warranties of any kind, including any warranty that the Website will be kept up to date, be true and not misleading, or that the Website will always (or ever) be available for use. Aptorum Group and its affiliates disclaim all warranties, express or implied, with respect to the Website and its contents, including, without limitation, any warranties of accuracy, completeness, timeliness, non-infringement, title, merchantability, or fitness for a particular purpose. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.

In no event will Aptorum Group or its affiliates be liable for any incidental, indirect, consequential, or special damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of profits, contracts, goodwill, data, information, income, anticipated savings, or business relationships, whether or not Aptorum Group or its affiliates have been advised of the possibility of such damage, arising out of or in connection with the use of this Website or its contents or any other sites linked to this Website.

If you have any concerns about material which appears on our Website, please contact us. We have the right and the ability to remove immediately from our Website any material that is infringing, defamatory, offensive, abusive, harming, deceptive, threatening or otherwise illegal.